Brokerages Set Bruker Co. (NASDAQ:BRKR) Price Target at $81.78

Bruker Co. (NASDAQ:BRKR) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $81.78.

Several research firms have weighed in on BRKR. Jefferies Financial Group began coverage on Bruker in a report on Monday, June 3rd. They set a “buy” rating and a $85.00 target price on the stock. Stifel Nicolaus reduced their target price on Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a report on Monday, May 20th. The Goldman Sachs Group reduced their target price on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, July 9th. Citigroup reduced their target price on Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th. Finally, Bank of America reduced their target price on Bruker from $95.00 to $90.00 and set a “buy” rating on the stock in a report on Monday, May 20th.

Hedge Funds Weigh In On Bruker

A number of institutional investors have recently bought and sold shares of BRKR. Norges Bank acquired a new position in Bruker during the fourth quarter worth approximately $74,582,000. TD Asset Management Inc increased its position in Bruker by 51.1% during the fourth quarter. TD Asset Management Inc now owns 1,664,779 shares of the medical research company’s stock worth $122,328,000 after buying an additional 562,684 shares during the last quarter. Handelsbanken Fonder AB boosted its holdings in shares of Bruker by 2,342.1% during the fourth quarter. Handelsbanken Fonder AB now owns 388,300 shares of the medical research company’s stock worth $28,532,000 after acquiring an additional 372,400 shares during the period. Public Employees Retirement Association of Colorado boosted its holdings in shares of Bruker by 925.8% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 362,035 shares of the medical research company’s stock worth $26,602,000 after acquiring an additional 326,741 shares during the period. Finally, Epoch Investment Partners Inc. boosted its holdings in shares of Bruker by 248.4% during the fourth quarter. Epoch Investment Partners Inc. now owns 405,436 shares of the medical research company’s stock worth $29,791,000 after acquiring an additional 289,055 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Stock Down 2.2 %

Shares of BRKR opened at $62.16 on Wednesday. Bruker has a 52 week low of $53.79 and a 52 week high of $94.86. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.91 and a current ratio of 1.81. The firm has a market capitalization of $9.03 billion, a price-to-earnings ratio of 22.60, a PEG ratio of 2.39 and a beta of 1.20. The business’s fifty day moving average price is $64.58 and its two-hundred day moving average price is $75.85.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.52. Bruker had a return on equity of 27.31% and a net margin of 13.38%. The business had revenue of $800.70 million for the quarter, compared to analyst estimates of $799.44 million. During the same period last year, the company earned $0.50 EPS. The firm’s revenue was up 17.4% on a year-over-year basis. On average, analysts predict that Bruker will post 2.66 earnings per share for the current year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 17th. Investors of record on Monday, June 3rd were given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date was Monday, June 3rd. Bruker’s dividend payout ratio is currently 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.